Dashboard
Manage Tickers

HYPR


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/16/2025 17:08:00

dow-dips-over-100-points-us-crude-oil-inventories-surge
Dow Dips Over 100 Points; US Crude Oil Inv...
10/16/2025 16:31:12

dow-surges-over-100-points-charles-schwab-posts-upbeat-earnings
Dow Surges Over 100 Points; Charles Schwab...
10/16/2025 14:00:35

hyperfine-prices-175m-public-offering-of-14m-shares-at-125share
Hyperfine Prices $17.5M Public Offering Of...
10/16/2025 12:09:11

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
10/16/2025 12:08:17

satellogic-hewlett-packard-enterprise-bitfarms-and-other-big-stocks-moving-lower-in-thursdays-pre-market-session
Satellogic, Hewlett Packard Enterprise, Bi...
10/16/2025 12:01:21

why-jb-hunt-transport-shares-are-trading-higher-by-13-here-are-20-stocks-moving-premarket
Why J.B. Hunt Transport Shares Are Trading...
10/16/2025 09:30:41

hyperfine-sees-q3-sales-3400m-vs-3507m-est
Hyperfine Sees Q3 Sales $3.400M vs $3.507M...
10/15/2025 22:46:03

Hyperfine (NASDAQ:HYPR) sees Q3 sales of $3.400 million vs $3.507 million analyst estimate.

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
10/15/2025 21:07:03

hyperfine-sees-prelim-q3-unaudited-revenue-34m-vs-3507m-est
Hyperfine Sees Prelim Q3 Unaudited Revenue...
10/15/2025 20:08:45

hyperfine-announces-proposed-public-offering-terms-not-disclosed
Hyperfine Announces Proposed Public Offeri...
10/15/2025 20:07:24

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 21:13:45

hyperfine-secures-ce-and-ukca-approvals-for-optive-ai-advancing-image-quality-for-portable-mri-across-europe
Hyperfine Secures CE and UKCA Approvals Fo...
09/02/2025 12:16:31

Approvals mark a major milestone and bring the most advanced image quality to date to Swoop® system users in European marketsHy...

wells-fargo-maintains-equal-weight-on-hyperfine-raises-price-target-to-085
Wells Fargo Maintains Equal-Weight on Hype...
08/15/2025 13:15:33

Wells Fargo analyst Larry Biegelsen maintains Hyperfine (NASDAQ:HYPR) with a Equal-Weight and raises the price target from $...

lake-street-maintains-buy-on-hyperfine-raises-price-target-to-2
Lake Street Maintains Buy on Hyperfine, Ra...
08/14/2025 16:48:39

Lake Street analyst Frank Takkinen maintains Hyperfine (NASDAQ:HYPR) with a Buy and raises the price target from $1.5 to $2.

hyperfine-affirms-fy2025-sales-guidance-of-14179m-15468m-vs-14193m-est
Hyperfine Affirms FY2025 Sales Guidance of...
08/13/2025 20:07:50

Hyperfine (NASDAQ:HYPR) affirms FY2025 sales outlook from $14.179 million-$15.468 million to $14.179 million-$15.468 million vs...

hyperfine-q2-eps-012-inline-sales-2696m-miss-3000m-estimate
Hyperfine Q2 EPS $(0.12), Inline, Sales $2...
08/13/2025 20:06:38

Hyperfine (NASDAQ:HYPR) reported quarterly losses of $(0.12) per share which met the analyst consensus estimate. This is a 14.2...

Core News & Articles
Earnings Scheduled For August 13, 2025
08/13/2025 08:32:30

hyperfine-announces-enrollment-of-100-patients-in-neuro-pmr-study-just-16-weeks-after-study-initiation-announced-on-april-15-2025
Hyperfine Announces Enrollment Of 100 Pati...
08/04/2025 12:19:19

NEURO PMR study evaluates the clinical utility and patient experience of AI-powered portable MRI in an outpatient settingHyperf...

hyperfine-launches-prime-study-to-evaluate-ai-powered-portable-mri-in-emergency-department-triage
Hyperfine Launches PRIME Study To Evaluate...
07/31/2025 12:26:48

The real-world study will assess the clinical and operational impact of portable MRI across diverse patient types in ED setting...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION